nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VCAM1—ulcerative colitis	0.322	0.687	CbGaD
Carvedilol—ADRB2—ulcerative colitis	0.0611	0.131	CbGaD
Carvedilol—PTGS1—ulcerative colitis	0.0573	0.122	CbGaD
Carvedilol—XDH—Mercaptopurine—ulcerative colitis	0.0496	0.151	CbGbCtD
Carvedilol—XDH—Azathioprine—ulcerative colitis	0.0496	0.151	CbGbCtD
Carvedilol—PTGS1—Olsalazine—ulcerative colitis	0.0296	0.0903	CbGbCtD
Carvedilol—ABCB1—ulcerative colitis	0.0278	0.0595	CbGaD
Carvedilol—PTGS1—Balsalazide—ulcerative colitis	0.0264	0.0805	CbGbCtD
Carvedilol—PTGS1—Mesalazine—ulcerative colitis	0.0211	0.0644	CbGbCtD
Carvedilol—CYP1A1—Nicotine—ulcerative colitis	0.0152	0.0462	CbGbCtD
Carvedilol—CYP1A1—Cholecalciferol—ulcerative colitis	0.0136	0.0415	CbGbCtD
Carvedilol—PTGS1—Sulfasalazine—ulcerative colitis	0.0118	0.036	CbGbCtD
Carvedilol—CYP2E1—Nicotine—ulcerative colitis	0.0117	0.0357	CbGbCtD
Carvedilol—CYP3A4—Budesonide—ulcerative colitis	0.00815	0.0249	CbGbCtD
Carvedilol—CYP1A2—Nicotine—ulcerative colitis	0.00677	0.0207	CbGbCtD
Carvedilol—CYP2C9—Nicotine—ulcerative colitis	0.0061	0.0186	CbGbCtD
Carvedilol—ABCB1—Methylprednisolone—ulcerative colitis	0.00608	0.0185	CbGbCtD
Carvedilol—CYP1A1—Dexamethasone—ulcerative colitis	0.00588	0.0179	CbGbCtD
Carvedilol—CYP2D6—Nicotine—ulcerative colitis	0.00558	0.017	CbGbCtD
Carvedilol—CYP2C9—Cholecalciferol—ulcerative colitis	0.00547	0.0167	CbGbCtD
Carvedilol—CYP2D6—Cholecalciferol—ulcerative colitis	0.00501	0.0153	CbGbCtD
Carvedilol—CYP2E1—Dexamethasone—ulcerative colitis	0.00455	0.0139	CbGbCtD
Carvedilol—ABCB1—Betamethasone—ulcerative colitis	0.00395	0.0121	CbGbCtD
Carvedilol—ABCB1—Prednisolone—ulcerative colitis	0.0039	0.0119	CbGbCtD
Carvedilol—ABCB1—Hydrocortisone—ulcerative colitis	0.0037	0.0113	CbGbCtD
Carvedilol—ABCB1—Prednisone—ulcerative colitis	0.00368	0.0112	CbGbCtD
Carvedilol—CYP3A4—Methylprednisolone—ulcerative colitis	0.00364	0.0111	CbGbCtD
Carvedilol—CYP3A4—Nicotine—ulcerative colitis	0.00355	0.0108	CbGbCtD
Carvedilol—CYP3A4—Cholecalciferol—ulcerative colitis	0.00318	0.00971	CbGbCtD
Carvedilol—CYP3A4—Triamcinolone—ulcerative colitis	0.00276	0.00842	CbGbCtD
Carvedilol—CYP2C9—Dexamethasone—ulcerative colitis	0.00237	0.00722	CbGbCtD
Carvedilol—CYP3A4—Betamethasone—ulcerative colitis	0.00237	0.00722	CbGbCtD
Carvedilol—CYP3A4—Prednisolone—ulcerative colitis	0.00234	0.00713	CbGbCtD
Carvedilol—ABCB1—Dexamethasone—ulcerative colitis	0.0023	0.00701	CbGbCtD
Carvedilol—CYP3A4—Hydrocortisone—ulcerative colitis	0.00221	0.00675	CbGbCtD
Carvedilol—CYP3A4—Prednisone—ulcerative colitis	0.00221	0.00673	CbGbCtD
Carvedilol—CYP2D6—Dexamethasone—ulcerative colitis	0.00217	0.00661	CbGbCtD
Carvedilol—NPPB—smooth muscle tissue—ulcerative colitis	0.00191	0.0561	CbGeAlD
Carvedilol—NPPB—lymphoid tissue—ulcerative colitis	0.00153	0.0448	CbGeAlD
Carvedilol—CYP3A4—Dexamethasone—ulcerative colitis	0.00138	0.0042	CbGbCtD
Carvedilol—SELE—epithelium—ulcerative colitis	0.00134	0.0393	CbGeAlD
Carvedilol—SELE—smooth muscle tissue—ulcerative colitis	0.00129	0.0379	CbGeAlD
Carvedilol—VCAM1—epithelium—ulcerative colitis	0.00123	0.0362	CbGeAlD
Carvedilol—VCAM1—smooth muscle tissue—ulcerative colitis	0.00119	0.0349	CbGeAlD
Carvedilol—HIF1A—epithelium—ulcerative colitis	0.00119	0.0348	CbGeAlD
Carvedilol—GJA1—epithelium—ulcerative colitis	0.00115	0.0338	CbGeAlD
Carvedilol—HIF1A—smooth muscle tissue—ulcerative colitis	0.00114	0.0335	CbGeAlD
Carvedilol—GJA1—smooth muscle tissue—ulcerative colitis	0.00111	0.0325	CbGeAlD
Carvedilol—SELE—lymphoid tissue—ulcerative colitis	0.00103	0.0303	CbGeAlD
Carvedilol—SELE—digestive system—ulcerative colitis	0.00102	0.0299	CbGeAlD
Carvedilol—NDUFC2—epithelium—ulcerative colitis	0.001	0.0294	CbGeAlD
Carvedilol—VCAM1—lymphoid tissue—ulcerative colitis	0.000949	0.0279	CbGeAlD
Carvedilol—VCAM1—digestive system—ulcerative colitis	0.000938	0.0275	CbGeAlD
Carvedilol—HIF1A—lymphoid tissue—ulcerative colitis	0.000913	0.0268	CbGeAlD
Carvedilol—HIF1A—digestive system—ulcerative colitis	0.000902	0.0265	CbGeAlD
Carvedilol—GJA1—lymphoid tissue—ulcerative colitis	0.000886	0.026	CbGeAlD
Carvedilol—VEGFA—smooth muscle tissue—ulcerative colitis	0.000875	0.0257	CbGeAlD
Carvedilol—GJA1—digestive system—ulcerative colitis	0.000875	0.0257	CbGeAlD
Carvedilol—NDUFC2—lymphoid tissue—ulcerative colitis	0.000771	0.0226	CbGeAlD
Carvedilol—NDUFC2—digestive system—ulcerative colitis	0.000762	0.0224	CbGeAlD
Carvedilol—SELE—liver—ulcerative colitis	0.000759	0.0223	CbGeAlD
Carvedilol—VCAM1—liver—ulcerative colitis	0.000699	0.0205	CbGeAlD
Carvedilol—HIF1A—liver—ulcerative colitis	0.000672	0.0197	CbGeAlD
Carvedilol—GJA1—liver—ulcerative colitis	0.000652	0.0191	CbGeAlD
Carvedilol—XDH—digestive system—ulcerative colitis	0.000615	0.0181	CbGeAlD
Carvedilol—ADRA1D—epithelium—ulcerative colitis	0.000593	0.0174	CbGeAlD
Carvedilol—NDUFC2—liver—ulcerative colitis	0.000567	0.0167	CbGeAlD
Carvedilol—Bevantolol—ADRB2—ulcerative colitis	0.000518	0.376	CrCbGaD
Carvedilol—VEGFA—liver—ulcerative colitis	0.000515	0.0151	CbGeAlD
Carvedilol—Bopindolol—ADRB2—ulcerative colitis	0.00048	0.348	CrCbGaD
Carvedilol—XDH—liver—ulcerative colitis	0.000458	0.0134	CbGeAlD
Carvedilol—ADRA1A—epithelium—ulcerative colitis	0.000341	0.01	CbGeAlD
Carvedilol—CYP1A1—epithelium—ulcerative colitis	0.000278	0.00816	CbGeAlD
Carvedilol—ADRA1A—lymphoid tissue—ulcerative colitis	0.000262	0.0077	CbGeAlD
Carvedilol—GJA1—Rimexolone—Budesonide—ulcerative colitis	0.000255	0.0911	CbGdCrCtD
Carvedilol—PTGS1—epithelium—ulcerative colitis	0.000244	0.00717	CbGeAlD
Carvedilol—PTGS1—smooth muscle tissue—ulcerative colitis	0.000235	0.00691	CbGeAlD
Carvedilol—CYP1A2—digestive system—ulcerative colitis	0.000214	0.00629	CbGeAlD
Carvedilol—CYP1A1—digestive system—ulcerative colitis	0.000211	0.00621	CbGeAlD
Carvedilol—CYP2C9—digestive system—ulcerative colitis	0.000204	0.00597	CbGeAlD
Carvedilol—CYP2E1—lymphoid tissue—ulcerative colitis	0.000195	0.00573	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Hydrocortisone—ulcerative colitis	0.000194	0.0693	CbGdCrCtD
Carvedilol—ADRA1A—liver—ulcerative colitis	0.000193	0.00567	CbGeAlD
Carvedilol—CYP2E1—digestive system—ulcerative colitis	0.000193	0.00566	CbGeAlD
Carvedilol—PTGS1—digestive system—ulcerative colitis	0.000186	0.00545	CbGeAlD
Carvedilol—ADRA2C—liver—ulcerative colitis	0.000184	0.0054	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Methylprednisolone—ulcerative colitis	0.000183	0.0654	CbGdCrCtD
Carvedilol—Propranolol—ADRB2—ulcerative colitis	0.00018	0.13	CrCbGaD
Carvedilol—GJA1—Cortisone acetate—Prednisone—ulcerative colitis	0.000167	0.0597	CbGdCrCtD
Carvedilol—GJA1—Cortisone acetate—Prednisolone—ulcerative colitis	0.000163	0.0582	CbGdCrCtD
Carvedilol—CYP1A2—liver—ulcerative colitis	0.00016	0.00469	CbGeAlD
Carvedilol—CYP1A1—liver—ulcerative colitis	0.000158	0.00462	CbGeAlD
Carvedilol—CYP3A4—digestive system—ulcerative colitis	0.000155	0.00455	CbGeAlD
Carvedilol—CYP2D6—digestive system—ulcerative colitis	0.000153	0.00448	CbGeAlD
Carvedilol—CYP2C9—liver—ulcerative colitis	0.000152	0.00445	CbGeAlD
Carvedilol—ABCB1—epithelium—ulcerative colitis	0.000144	0.00424	CbGeAlD
Carvedilol—CYP2E1—liver—ulcerative colitis	0.000144	0.00422	CbGeAlD
Carvedilol—GJA1—Rimexolone—Hydrocortisone—ulcerative colitis	0.00013	0.0466	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Methylprednisolone—ulcerative colitis	0.000123	0.044	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Betamethasone—ulcerative colitis	0.000121	0.0433	CbGdCrCtD
Carvedilol—GJA1—Rimexolone—Dexamethasone—ulcerative colitis	0.000121	0.0433	CbGdCrCtD
Carvedilol—Propafenone—ABCB1—ulcerative colitis	0.00012	0.0868	CrCbGaD
Carvedilol—GJA1—Rimexolone—Triamcinolone—ulcerative colitis	0.000118	0.0423	CbGdCrCtD
Carvedilol—CYP3A4—liver—ulcerative colitis	0.000116	0.00339	CbGeAlD
Carvedilol—CYP2D6—liver—ulcerative colitis	0.000114	0.00334	CbGeAlD
Carvedilol—GJA1—Rimexolone—Prednisone—ulcerative colitis	0.000112	0.0401	CbGdCrCtD
Carvedilol—ABCB1—lymphoid tissue—ulcerative colitis	0.000111	0.00326	CbGeAlD
Carvedilol—ABCB1—digestive system—ulcerative colitis	0.00011	0.00322	CbGeAlD
Carvedilol—GJA1—Rimexolone—Prednisolone—ulcerative colitis	0.00011	0.0392	CbGdCrCtD
Carvedilol—GJA1—Progesterone—Hydrocortisone—ulcerative colitis	9.48e-05	0.0339	CbGdCrCtD
Carvedilol—Propranolol—ABCB1—ulcerative colitis	8.21e-05	0.0595	CrCbGaD
Carvedilol—ABCB1—liver—ulcerative colitis	8.18e-05	0.0024	CbGeAlD
Carvedilol—GJA1—Progesterone—Prednisolone—ulcerative colitis	7.97e-05	0.0285	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Budesonide—ulcerative colitis	5.77e-05	0.0206	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Budesonide—ulcerative colitis	5.77e-05	0.0206	CbGdCrCtD
Carvedilol—Oedema—Hydrocortisone—ulcerative colitis	5.15e-05	0.000586	CcSEcCtD
Carvedilol—Convulsion—Triamcinolone—ulcerative colitis	5.15e-05	0.000586	CcSEcCtD
Carvedilol—Tachycardia—Prednisolone—ulcerative colitis	5.15e-05	0.000586	CcSEcCtD
Carvedilol—Convulsion—Methylprednisolone—ulcerative colitis	5.14e-05	0.000585	CcSEcCtD
Carvedilol—Hypertension—Triamcinolone—ulcerative colitis	5.13e-05	0.000584	CcSEcCtD
Carvedilol—Pruritus—Mesalazine—ulcerative colitis	5.13e-05	0.000583	CcSEcCtD
Carvedilol—Hypertension—Methylprednisolone—ulcerative colitis	5.12e-05	0.000583	CcSEcCtD
Carvedilol—Infection—Hydrocortisone—ulcerative colitis	5.12e-05	0.000583	CcSEcCtD
Carvedilol—Hyperhidrosis—Prednisolone—ulcerative colitis	5.1e-05	0.00058	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Budesonide—ulcerative colitis	5.08e-05	0.0182	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Budesonide—ulcerative colitis	5.08e-05	0.0182	CbGdCrCtD
Carvedilol—Shock—Hydrocortisone—ulcerative colitis	5.07e-05	0.000577	CcSEcCtD
Carvedilol—Myalgia—Triamcinolone—ulcerative colitis	5.06e-05	0.000576	CcSEcCtD
Carvedilol—Vomiting—Azathioprine—ulcerative colitis	5.06e-05	0.000576	CcSEcCtD
Carvedilol—Myalgia—Methylprednisolone—ulcerative colitis	5.05e-05	0.000575	CcSEcCtD
Carvedilol—Arthralgia—Methylprednisolone—ulcerative colitis	5.05e-05	0.000575	CcSEcCtD
Carvedilol—Tachycardia—Hydrocortisone—ulcerative colitis	5.03e-05	0.000572	CcSEcCtD
Carvedilol—Rash—Azathioprine—ulcerative colitis	5.02e-05	0.000571	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	5.01e-05	0.000571	CcSEcCtD
Carvedilol—Dermatitis—Azathioprine—ulcerative colitis	5.01e-05	0.00057	CcSEcCtD
Carvedilol—Skin disorder—Hydrocortisone—ulcerative colitis	5e-05	0.00057	CcSEcCtD
Carvedilol—Ill-defined disorder—Betamethasone—ulcerative colitis	5e-05	0.00057	CcSEcCtD
Carvedilol—Ill-defined disorder—Dexamethasone—ulcerative colitis	5e-05	0.00057	CcSEcCtD
Carvedilol—Discomfort—Triamcinolone—ulcerative colitis	5e-05	0.000569	CcSEcCtD
Carvedilol—Discomfort—Methylprednisolone—ulcerative colitis	4.99e-05	0.000568	CcSEcCtD
Carvedilol—Headache—Azathioprine—ulcerative colitis	4.98e-05	0.000567	CcSEcCtD
Carvedilol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.98e-05	0.000567	CcSEcCtD
Carvedilol—Diarrhoea—Mesalazine—ulcerative colitis	4.96e-05	0.000564	CcSEcCtD
Carvedilol—Dry mouth—Triamcinolone—ulcerative colitis	4.95e-05	0.000563	CcSEcCtD
Carvedilol—Angioedema—Dexamethasone—ulcerative colitis	4.93e-05	0.000561	CcSEcCtD
Carvedilol—Angioedema—Betamethasone—ulcerative colitis	4.93e-05	0.000561	CcSEcCtD
Carvedilol—Anorexia—Hydrocortisone—ulcerative colitis	4.91e-05	0.000559	CcSEcCtD
Carvedilol—Angiopathy—Prednisone—ulcerative colitis	4.9e-05	0.000557	CcSEcCtD
Carvedilol—Confusional state—Methylprednisolone—ulcerative colitis	4.88e-05	0.000556	CcSEcCtD
Carvedilol—Immune system disorder—Prednisone—ulcerative colitis	4.87e-05	0.000555	CcSEcCtD
Carvedilol—Malaise—Dexamethasone—ulcerative colitis	4.86e-05	0.000554	CcSEcCtD
Carvedilol—Malaise—Betamethasone—ulcerative colitis	4.86e-05	0.000554	CcSEcCtD
Carvedilol—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.85e-05	0.000552	CcSEcCtD
Carvedilol—Oedema—Triamcinolone—ulcerative colitis	4.85e-05	0.000552	CcSEcCtD
Carvedilol—Vertigo—Betamethasone—ulcerative colitis	4.85e-05	0.000552	CcSEcCtD
Carvedilol—Vertigo—Dexamethasone—ulcerative colitis	4.85e-05	0.000552	CcSEcCtD
Carvedilol—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.84e-05	0.000551	CcSEcCtD
Carvedilol—Syncope—Betamethasone—ulcerative colitis	4.84e-05	0.000551	CcSEcCtD
Carvedilol—Syncope—Dexamethasone—ulcerative colitis	4.84e-05	0.000551	CcSEcCtD
Carvedilol—Infection—Triamcinolone—ulcerative colitis	4.82e-05	0.000549	CcSEcCtD
Carvedilol—Hypotension—Hydrocortisone—ulcerative colitis	4.81e-05	0.000548	CcSEcCtD
Carvedilol—Infection—Methylprednisolone—ulcerative colitis	4.81e-05	0.000547	CcSEcCtD
Carvedilol—Dizziness—Mesalazine—ulcerative colitis	4.79e-05	0.000545	CcSEcCtD
Carvedilol—Shock—Triamcinolone—ulcerative colitis	4.77e-05	0.000543	CcSEcCtD
Carvedilol—Insomnia—Prednisolone—ulcerative colitis	4.77e-05	0.000543	CcSEcCtD
Carvedilol—Alopecia—Prednisone—ulcerative colitis	4.77e-05	0.000543	CcSEcCtD
Carvedilol—Shock—Methylprednisolone—ulcerative colitis	4.76e-05	0.000542	CcSEcCtD
Carvedilol—Loss of consciousness—Dexamethasone—ulcerative colitis	4.74e-05	0.00054	CcSEcCtD
Carvedilol—Loss of consciousness—Betamethasone—ulcerative colitis	4.74e-05	0.00054	CcSEcCtD
Carvedilol—Paraesthesia—Prednisolone—ulcerative colitis	4.74e-05	0.000539	CcSEcCtD
Carvedilol—Tachycardia—Triamcinolone—ulcerative colitis	4.74e-05	0.000539	CcSEcCtD
Carvedilol—Nausea—Azathioprine—ulcerative colitis	4.73e-05	0.000538	CcSEcCtD
Carvedilol—Tachycardia—Methylprednisolone—ulcerative colitis	4.72e-05	0.000538	CcSEcCtD
Carvedilol—Skin disorder—Methylprednisolone—ulcerative colitis	4.7e-05	0.000535	CcSEcCtD
Carvedilol—Malnutrition—Prednisone—ulcerative colitis	4.7e-05	0.000535	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.69e-05	0.000534	CcSEcCtD
Carvedilol—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.69e-05	0.000534	CcSEcCtD
Carvedilol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.68e-05	0.000533	CcSEcCtD
Carvedilol—Convulsion—Betamethasone—ulcerative colitis	4.67e-05	0.000532	CcSEcCtD
Carvedilol—Convulsion—Dexamethasone—ulcerative colitis	4.67e-05	0.000532	CcSEcCtD
Carvedilol—Insomnia—Hydrocortisone—ulcerative colitis	4.66e-05	0.00053	CcSEcCtD
Carvedilol—Hypertension—Betamethasone—ulcerative colitis	4.66e-05	0.00053	CcSEcCtD
Carvedilol—Hypertension—Dexamethasone—ulcerative colitis	4.66e-05	0.00053	CcSEcCtD
Carvedilol—Paraesthesia—Hydrocortisone—ulcerative colitis	4.63e-05	0.000527	CcSEcCtD
Carvedilol—Vomiting—Mesalazine—ulcerative colitis	4.61e-05	0.000524	CcSEcCtD
Carvedilol—Myalgia—Dexamethasone—ulcerative colitis	4.59e-05	0.000523	CcSEcCtD
Carvedilol—Myalgia—Betamethasone—ulcerative colitis	4.59e-05	0.000523	CcSEcCtD
Carvedilol—Rash—Mesalazine—ulcerative colitis	4.57e-05	0.00052	CcSEcCtD
Carvedilol—Dermatitis—Mesalazine—ulcerative colitis	4.56e-05	0.00052	CcSEcCtD
Carvedilol—Headache—Mesalazine—ulcerative colitis	4.54e-05	0.000517	CcSEcCtD
Carvedilol—Discomfort—Dexamethasone—ulcerative colitis	4.54e-05	0.000516	CcSEcCtD
Carvedilol—Discomfort—Betamethasone—ulcerative colitis	4.54e-05	0.000516	CcSEcCtD
Carvedilol—Dyspepsia—Hydrocortisone—ulcerative colitis	4.54e-05	0.000516	CcSEcCtD
Carvedilol—Hypotension—Methylprednisolone—ulcerative colitis	4.52e-05	0.000515	CcSEcCtD
Carvedilol—Pain—Prednisolone—ulcerative colitis	4.51e-05	0.000513	CcSEcCtD
Carvedilol—Decreased appetite—Hydrocortisone—ulcerative colitis	4.48e-05	0.00051	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.45e-05	0.000506	CcSEcCtD
Carvedilol—Fatigue—Hydrocortisone—ulcerative colitis	4.44e-05	0.000506	CcSEcCtD
Carvedilol—Vision blurred—Prednisone—ulcerative colitis	4.43e-05	0.000504	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.42e-05	0.000503	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.41e-05	0.000502	CcSEcCtD
Carvedilol—Pain—Hydrocortisone—ulcerative colitis	4.41e-05	0.000501	CcSEcCtD
Carvedilol—Oedema—Dexamethasone—ulcerative colitis	4.4e-05	0.000501	CcSEcCtD
Carvedilol—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.4e-05	0.000501	CcSEcCtD
Carvedilol—Anaphylactic shock—Betamethasone—ulcerative colitis	4.4e-05	0.000501	CcSEcCtD
Carvedilol—Oedema—Betamethasone—ulcerative colitis	4.4e-05	0.000501	CcSEcCtD
Carvedilol—Insomnia—Triamcinolone—ulcerative colitis	4.39e-05	0.000499	CcSEcCtD
Carvedilol—Insomnia—Methylprednisolone—ulcerative colitis	4.38e-05	0.000498	CcSEcCtD
Carvedilol—Infection—Dexamethasone—ulcerative colitis	4.37e-05	0.000498	CcSEcCtD
Carvedilol—Infection—Betamethasone—ulcerative colitis	4.37e-05	0.000498	CcSEcCtD
Carvedilol—Ill-defined disorder—Prednisone—ulcerative colitis	4.36e-05	0.000496	CcSEcCtD
Carvedilol—Paraesthesia—Triamcinolone—ulcerative colitis	4.36e-05	0.000496	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisolone—ulcerative colitis	4.35e-05	0.000495	CcSEcCtD
Carvedilol—Paraesthesia—Methylprednisolone—ulcerative colitis	4.35e-05	0.000495	CcSEcCtD
Carvedilol—Anaemia—Prednisone—ulcerative colitis	4.34e-05	0.000494	CcSEcCtD
Carvedilol—Shock—Dexamethasone—ulcerative colitis	4.33e-05	0.000493	CcSEcCtD
Carvedilol—Shock—Betamethasone—ulcerative colitis	4.33e-05	0.000493	CcSEcCtD
Carvedilol—Dyspnoea—Triamcinolone—ulcerative colitis	4.33e-05	0.000492	CcSEcCtD
Carvedilol—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.31e-05	0.000491	CcSEcCtD
Carvedilol—Thrombocytopenia—Betamethasone—ulcerative colitis	4.31e-05	0.000491	CcSEcCtD
Carvedilol—Nausea—Mesalazine—ulcerative colitis	4.3e-05	0.00049	CcSEcCtD
Carvedilol—Tachycardia—Dexamethasone—ulcerative colitis	4.3e-05	0.000489	CcSEcCtD
Carvedilol—Tachycardia—Betamethasone—ulcerative colitis	4.3e-05	0.000489	CcSEcCtD
Carvedilol—Angioedema—Prednisone—ulcerative colitis	4.29e-05	0.000489	CcSEcCtD
Carvedilol—Dyspepsia—Triamcinolone—ulcerative colitis	4.27e-05	0.000486	CcSEcCtD
Carvedilol—Dyspepsia—Methylprednisolone—ulcerative colitis	4.26e-05	0.000485	CcSEcCtD
Carvedilol—Hyperhidrosis—Dexamethasone—ulcerative colitis	4.26e-05	0.000484	CcSEcCtD
Carvedilol—Hyperhidrosis—Betamethasone—ulcerative colitis	4.26e-05	0.000484	CcSEcCtD
Carvedilol—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.25e-05	0.000483	CcSEcCtD
Carvedilol—Malaise—Prednisone—ulcerative colitis	4.24e-05	0.000482	CcSEcCtD
Carvedilol—Vertigo—Prednisone—ulcerative colitis	4.22e-05	0.00048	CcSEcCtD
Carvedilol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.21e-05	0.00048	CcSEcCtD
Carvedilol—Syncope—Prednisone—ulcerative colitis	4.21e-05	0.000479	CcSEcCtD
Carvedilol—Anorexia—Betamethasone—ulcerative colitis	4.2e-05	0.000478	CcSEcCtD
Carvedilol—Anorexia—Dexamethasone—ulcerative colitis	4.2e-05	0.000478	CcSEcCtD
Carvedilol—Urticaria—Prednisolone—ulcerative colitis	4.19e-05	0.000477	CcSEcCtD
Carvedilol—Fatigue—Triamcinolone—ulcerative colitis	4.18e-05	0.000476	CcSEcCtD
Carvedilol—Fatigue—Methylprednisolone—ulcerative colitis	4.17e-05	0.000475	CcSEcCtD
Carvedilol—Pain—Triamcinolone—ulcerative colitis	4.15e-05	0.000472	CcSEcCtD
Carvedilol—Loss of consciousness—Prednisone—ulcerative colitis	4.13e-05	0.00047	CcSEcCtD
Carvedilol—Hypotension—Betamethasone—ulcerative colitis	4.11e-05	0.000468	CcSEcCtD
Carvedilol—Hypotension—Dexamethasone—ulcerative colitis	4.11e-05	0.000468	CcSEcCtD
Carvedilol—Urticaria—Hydrocortisone—ulcerative colitis	4.09e-05	0.000466	CcSEcCtD
Carvedilol—Abdominal pain—Hydrocortisone—ulcerative colitis	4.07e-05	0.000464	CcSEcCtD
Carvedilol—Body temperature increased—Hydrocortisone—ulcerative colitis	4.07e-05	0.000464	CcSEcCtD
Carvedilol—Convulsion—Prednisone—ulcerative colitis	4.07e-05	0.000463	CcSEcCtD
Carvedilol—Hypertension—Prednisone—ulcerative colitis	4.06e-05	0.000462	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.01e-05	0.000456	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.01e-05	0.000456	CcSEcCtD
Carvedilol—Myalgia—Prednisone—ulcerative colitis	4e-05	0.000455	CcSEcCtD
Carvedilol—Arthralgia—Prednisone—ulcerative colitis	4e-05	0.000455	CcSEcCtD
Carvedilol—Feeling abnormal—Triamcinolone—ulcerative colitis	4e-05	0.000455	CcSEcCtD
Carvedilol—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.99e-05	0.000454	CcSEcCtD
Carvedilol—Insomnia—Betamethasone—ulcerative colitis	3.98e-05	0.000453	CcSEcCtD
Carvedilol—Insomnia—Dexamethasone—ulcerative colitis	3.98e-05	0.000453	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.97e-05	0.000452	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.96e-05	0.000451	CcSEcCtD
Carvedilol—Paraesthesia—Betamethasone—ulcerative colitis	3.95e-05	0.00045	CcSEcCtD
Carvedilol—Paraesthesia—Dexamethasone—ulcerative colitis	3.95e-05	0.00045	CcSEcCtD
Carvedilol—Discomfort—Prednisone—ulcerative colitis	3.95e-05	0.00045	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisolone—ulcerative colitis	3.89e-05	0.000442	CcSEcCtD
Carvedilol—Dyspepsia—Betamethasone—ulcerative colitis	3.88e-05	0.000441	CcSEcCtD
Carvedilol—Dyspepsia—Dexamethasone—ulcerative colitis	3.88e-05	0.000441	CcSEcCtD
Carvedilol—Urticaria—Triamcinolone—ulcerative colitis	3.85e-05	0.000439	CcSEcCtD
Carvedilol—Urticaria—Methylprednisolone—ulcerative colitis	3.85e-05	0.000438	CcSEcCtD
Carvedilol—Body temperature increased—Triamcinolone—ulcerative colitis	3.84e-05	0.000437	CcSEcCtD
Carvedilol—Oedema—Prednisone—ulcerative colitis	3.83e-05	0.000436	CcSEcCtD
Carvedilol—Anaphylactic shock—Prednisone—ulcerative colitis	3.83e-05	0.000436	CcSEcCtD
Carvedilol—Abdominal pain—Methylprednisolone—ulcerative colitis	3.83e-05	0.000436	CcSEcCtD
Carvedilol—Decreased appetite—Dexamethasone—ulcerative colitis	3.83e-05	0.000436	CcSEcCtD
Carvedilol—Decreased appetite—Betamethasone—ulcerative colitis	3.83e-05	0.000436	CcSEcCtD
Carvedilol—Infection—Prednisone—ulcerative colitis	3.81e-05	0.000433	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.8e-05	0.000433	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.8e-05	0.000433	CcSEcCtD
Carvedilol—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.8e-05	0.000432	CcSEcCtD
Carvedilol—Fatigue—Dexamethasone—ulcerative colitis	3.8e-05	0.000432	CcSEcCtD
Carvedilol—Fatigue—Betamethasone—ulcerative colitis	3.8e-05	0.000432	CcSEcCtD
Carvedilol—Shock—Prednisone—ulcerative colitis	3.77e-05	0.000429	CcSEcCtD
Carvedilol—Pain—Betamethasone—ulcerative colitis	3.76e-05	0.000428	CcSEcCtD
Carvedilol—Pain—Dexamethasone—ulcerative colitis	3.76e-05	0.000428	CcSEcCtD
Carvedilol—Tachycardia—Prednisone—ulcerative colitis	3.74e-05	0.000426	CcSEcCtD
Carvedilol—Skin disorder—Prednisone—ulcerative colitis	3.72e-05	0.000424	CcSEcCtD
Carvedilol—Hyperhidrosis—Prednisone—ulcerative colitis	3.71e-05	0.000422	CcSEcCtD
Carvedilol—Asthenia—Hydrocortisone—ulcerative colitis	3.7e-05	0.000421	CcSEcCtD
Carvedilol—Anorexia—Prednisone—ulcerative colitis	3.65e-05	0.000416	CcSEcCtD
Carvedilol—Pruritus—Hydrocortisone—ulcerative colitis	3.65e-05	0.000415	CcSEcCtD
Carvedilol—Feeling abnormal—Dexamethasone—ulcerative colitis	3.63e-05	0.000413	CcSEcCtD
Carvedilol—Feeling abnormal—Betamethasone—ulcerative colitis	3.63e-05	0.000413	CcSEcCtD
Carvedilol—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.6e-05	0.00041	CcSEcCtD
Carvedilol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.6e-05	0.00041	CcSEcCtD
Carvedilol—Hypersensitivity—Triamcinolone—ulcerative colitis	3.57e-05	0.000407	CcSEcCtD
Carvedilol—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.57e-05	0.000406	CcSEcCtD
Carvedilol—Diarrhoea—Hydrocortisone—ulcerative colitis	3.53e-05	0.000401	CcSEcCtD
Carvedilol—Urticaria—Dexamethasone—ulcerative colitis	3.5e-05	0.000398	CcSEcCtD
Carvedilol—Urticaria—Betamethasone—ulcerative colitis	3.5e-05	0.000398	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.49e-05	0.000398	CcSEcCtD
Carvedilol—Dizziness—Prednisolone—ulcerative colitis	3.49e-05	0.000397	CcSEcCtD
Carvedilol—Asthenia—Triamcinolone—ulcerative colitis	3.48e-05	0.000396	CcSEcCtD
Carvedilol—Body temperature increased—Betamethasone—ulcerative colitis	3.48e-05	0.000396	CcSEcCtD
Carvedilol—Abdominal pain—Dexamethasone—ulcerative colitis	3.48e-05	0.000396	CcSEcCtD
Carvedilol—Abdominal pain—Betamethasone—ulcerative colitis	3.48e-05	0.000396	CcSEcCtD
Carvedilol—Body temperature increased—Dexamethasone—ulcerative colitis	3.48e-05	0.000396	CcSEcCtD
Carvedilol—Asthenia—Methylprednisolone—ulcerative colitis	3.47e-05	0.000395	CcSEcCtD
Carvedilol—Insomnia—Prednisone—ulcerative colitis	3.47e-05	0.000395	CcSEcCtD
Carvedilol—Paraesthesia—Prednisone—ulcerative colitis	3.44e-05	0.000392	CcSEcCtD
Carvedilol—Pruritus—Triamcinolone—ulcerative colitis	3.43e-05	0.000391	CcSEcCtD
Carvedilol—Pruritus—Methylprednisolone—ulcerative colitis	3.42e-05	0.00039	CcSEcCtD
Carvedilol—Dizziness—Hydrocortisone—ulcerative colitis	3.41e-05	0.000388	CcSEcCtD
Carvedilol—Dyspepsia—Prednisone—ulcerative colitis	3.37e-05	0.000384	CcSEcCtD
Carvedilol—Decreased appetite—Prednisone—ulcerative colitis	3.33e-05	0.000379	CcSEcCtD
Carvedilol—Rash—Prednisolone—ulcerative colitis	3.33e-05	0.000379	CcSEcCtD
Carvedilol—Dermatitis—Prednisolone—ulcerative colitis	3.32e-05	0.000378	CcSEcCtD
Carvedilol—Diarrhoea—Methylprednisolone—ulcerative colitis	3.31e-05	0.000377	CcSEcCtD
Carvedilol—Fatigue—Prednisone—ulcerative colitis	3.31e-05	0.000376	CcSEcCtD
Carvedilol—Headache—Prednisolone—ulcerative colitis	3.31e-05	0.000376	CcSEcCtD
Carvedilol—Constipation—Prednisone—ulcerative colitis	3.28e-05	0.000373	CcSEcCtD
Carvedilol—Vomiting—Hydrocortisone—ulcerative colitis	3.28e-05	0.000373	CcSEcCtD
Carvedilol—Rash—Hydrocortisone—ulcerative colitis	3.25e-05	0.00037	CcSEcCtD
Carvedilol—Dermatitis—Hydrocortisone—ulcerative colitis	3.25e-05	0.000369	CcSEcCtD
Carvedilol—Headache—Hydrocortisone—ulcerative colitis	3.23e-05	0.000367	CcSEcCtD
Carvedilol—Dizziness—Triamcinolone—ulcerative colitis	3.21e-05	0.000365	CcSEcCtD
Carvedilol—Dizziness—Methylprednisolone—ulcerative colitis	3.2e-05	0.000364	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisone—ulcerative colitis	3.16e-05	0.00036	CcSEcCtD
Carvedilol—Asthenia—Betamethasone—ulcerative colitis	3.16e-05	0.000359	CcSEcCtD
Carvedilol—Asthenia—Dexamethasone—ulcerative colitis	3.16e-05	0.000359	CcSEcCtD
Carvedilol—Gastrointestinal pain—Prednisone—ulcerative colitis	3.13e-05	0.000357	CcSEcCtD
Carvedilol—Nausea—Prednisolone—ulcerative colitis	3.13e-05	0.000357	CcSEcCtD
Carvedilol—Pruritus—Betamethasone—ulcerative colitis	3.11e-05	0.000354	CcSEcCtD
Carvedilol—Pruritus—Dexamethasone—ulcerative colitis	3.11e-05	0.000354	CcSEcCtD
Carvedilol—Vomiting—Triamcinolone—ulcerative colitis	3.08e-05	0.000351	CcSEcCtD
Carvedilol—Vomiting—Methylprednisolone—ulcerative colitis	3.08e-05	0.00035	CcSEcCtD
Carvedilol—Nausea—Hydrocortisone—ulcerative colitis	3.06e-05	0.000348	CcSEcCtD
Carvedilol—Rash—Triamcinolone—ulcerative colitis	3.06e-05	0.000348	CcSEcCtD
Carvedilol—Dermatitis—Triamcinolone—ulcerative colitis	3.06e-05	0.000348	CcSEcCtD
Carvedilol—Rash—Methylprednisolone—ulcerative colitis	3.05e-05	0.000347	CcSEcCtD
Carvedilol—Dermatitis—Methylprednisolone—ulcerative colitis	3.05e-05	0.000347	CcSEcCtD
Carvedilol—Urticaria—Prednisone—ulcerative colitis	3.05e-05	0.000347	CcSEcCtD
Carvedilol—Headache—Triamcinolone—ulcerative colitis	3.04e-05	0.000346	CcSEcCtD
Carvedilol—Headache—Methylprednisolone—ulcerative colitis	3.03e-05	0.000345	CcSEcCtD
Carvedilol—Abdominal pain—Prednisone—ulcerative colitis	3.03e-05	0.000345	CcSEcCtD
Carvedilol—Body temperature increased—Prednisone—ulcerative colitis	3.03e-05	0.000345	CcSEcCtD
Carvedilol—Diarrhoea—Betamethasone—ulcerative colitis	3.01e-05	0.000343	CcSEcCtD
Carvedilol—Diarrhoea—Dexamethasone—ulcerative colitis	3.01e-05	0.000343	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Hydrocortisone—ulcerative colitis	2.95e-05	0.0106	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Hydrocortisone—ulcerative colitis	2.95e-05	0.0106	CbGdCrCtD
Carvedilol—Dizziness—Dexamethasone—ulcerative colitis	2.91e-05	0.000331	CcSEcCtD
Carvedilol—Dizziness—Betamethasone—ulcerative colitis	2.91e-05	0.000331	CcSEcCtD
Carvedilol—Nausea—Triamcinolone—ulcerative colitis	2.88e-05	0.000328	CcSEcCtD
Carvedilol—Nausea—Methylprednisolone—ulcerative colitis	2.88e-05	0.000327	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisone—ulcerative colitis	2.82e-05	0.000321	CcSEcCtD
Carvedilol—Vomiting—Betamethasone—ulcerative colitis	2.8e-05	0.000319	CcSEcCtD
Carvedilol—Vomiting—Dexamethasone—ulcerative colitis	2.8e-05	0.000319	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Methylprednisolone—ulcerative colitis	2.78e-05	0.00996	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Methylprednisolone—ulcerative colitis	2.78e-05	0.00996	CbGdCrCtD
Carvedilol—Rash—Betamethasone—ulcerative colitis	2.78e-05	0.000316	CcSEcCtD
Carvedilol—Rash—Dexamethasone—ulcerative colitis	2.78e-05	0.000316	CcSEcCtD
Carvedilol—Dermatitis—Betamethasone—ulcerative colitis	2.77e-05	0.000316	CcSEcCtD
Carvedilol—Dermatitis—Dexamethasone—ulcerative colitis	2.77e-05	0.000316	CcSEcCtD
Carvedilol—Headache—Dexamethasone—ulcerative colitis	2.76e-05	0.000314	CcSEcCtD
Carvedilol—Headache—Betamethasone—ulcerative colitis	2.76e-05	0.000314	CcSEcCtD
Carvedilol—Asthenia—Prednisone—ulcerative colitis	2.75e-05	0.000313	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Betamethasone—ulcerative colitis	2.74e-05	0.0098	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Dexamethasone—ulcerative colitis	2.74e-05	0.0098	CbGdCrCtD
Carvedilol—Pruritus—Prednisone—ulcerative colitis	2.71e-05	0.000309	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Triamcinolone—ulcerative colitis	2.68e-05	0.00958	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Triamcinolone—ulcerative colitis	2.68e-05	0.00958	CbGdCrCtD
Carvedilol—Diarrhoea—Prednisone—ulcerative colitis	2.62e-05	0.000299	CcSEcCtD
Carvedilol—Nausea—Betamethasone—ulcerative colitis	2.61e-05	0.000298	CcSEcCtD
Carvedilol—Nausea—Dexamethasone—ulcerative colitis	2.61e-05	0.000298	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Hydrocortisone—ulcerative colitis	2.6e-05	0.0093	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Hydrocortisone—ulcerative colitis	2.6e-05	0.0093	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Prednisone—ulcerative colitis	2.54e-05	0.00909	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Prednisone—ulcerative colitis	2.54e-05	0.00909	CbGdCrCtD
Carvedilol—Dizziness—Prednisone—ulcerative colitis	2.54e-05	0.000289	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Prednisolone—ulcerative colitis	2.48e-05	0.00887	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Prednisolone—ulcerative colitis	2.48e-05	0.00887	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Methylprednisolone—ulcerative colitis	2.45e-05	0.00878	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Methylprednisolone—ulcerative colitis	2.45e-05	0.00878	CbGdCrCtD
Carvedilol—Vomiting—Prednisone—ulcerative colitis	2.44e-05	0.000277	CcSEcCtD
Carvedilol—Rash—Prednisone—ulcerative colitis	2.42e-05	0.000275	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Betamethasone—ulcerative colitis	2.42e-05	0.00864	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Dexamethasone—ulcerative colitis	2.42e-05	0.00864	CbGdCrCtD
Carvedilol—Dermatitis—Prednisone—ulcerative colitis	2.41e-05	0.000275	CcSEcCtD
Carvedilol—Headache—Prednisone—ulcerative colitis	2.4e-05	0.000273	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Triamcinolone—ulcerative colitis	2.36e-05	0.00844	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Triamcinolone—ulcerative colitis	2.36e-05	0.00844	CbGdCrCtD
Carvedilol—Nausea—Prednisone—ulcerative colitis	2.28e-05	0.000259	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Prednisone—ulcerative colitis	2.24e-05	0.00801	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisone—ulcerative colitis	2.24e-05	0.00801	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Prednisolone—ulcerative colitis	2.19e-05	0.00782	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisolone—ulcerative colitis	2.19e-05	0.00782	CbGdCrCtD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.23e-06	5.41e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	4.21e-06	5.4e-05	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.21e-06	5.39e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ADRB2—ulcerative colitis	4.21e-06	5.39e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	4.2e-06	5.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	4.19e-06	5.37e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	4.18e-06	5.35e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TGFB1—ulcerative colitis	4.18e-06	5.35e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	4.15e-06	5.32e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	4.15e-06	5.32e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CALM3—ulcerative colitis	4.1e-06	5.25e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	4.1e-06	5.25e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	4.02e-06	5.15e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	4.01e-06	5.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ADCY5—ulcerative colitis	3.99e-06	5.11e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ADCY5—ulcerative colitis	3.98e-06	5.1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	3.96e-06	5.07e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	3.96e-06	5.07e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	3.93e-06	5.03e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	3.88e-06	4.97e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	3.87e-06	4.96e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CALM3—ulcerative colitis	3.87e-06	4.95e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	3.86e-06	4.94e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	3.83e-06	4.9e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	3.82e-06	4.89e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	3.81e-06	4.88e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	3.81e-06	4.87e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	3.79e-06	4.85e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	3.79e-06	4.85e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—JAK2—ulcerative colitis	3.78e-06	4.84e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	3.77e-06	4.83e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	3.74e-06	4.79e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	3.74e-06	4.78e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	3.72e-06	4.77e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.7e-06	4.73e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	3.68e-06	4.71e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—ulcerative colitis	3.68e-06	4.71e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—RELA—ulcerative colitis	3.67e-06	4.7e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—RELA—ulcerative colitis	3.66e-06	4.69e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	3.66e-06	4.68e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	3.64e-06	4.66e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	3.62e-06	4.64e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	3.61e-06	4.62e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	3.58e-06	4.58e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	3.57e-06	4.58e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	3.54e-06	4.53e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	3.53e-06	4.52e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	3.52e-06	4.51e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.51e-06	4.49e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	3.48e-06	4.46e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ABCB1—ulcerative colitis	3.48e-06	4.45e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	3.47e-06	4.45e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	3.47e-06	4.44e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	3.46e-06	4.43e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CXCL8—ulcerative colitis	3.45e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	3.44e-06	4.41e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—ulcerative colitis	3.44e-06	4.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	3.44e-06	4.4e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS1—ulcerative colitis	3.43e-06	4.39e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	3.4e-06	4.35e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	3.39e-06	4.34e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	3.39e-06	4.34e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	3.38e-06	4.33e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	3.34e-06	4.27e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	3.33e-06	4.26e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	3.32e-06	4.25e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL2—ulcerative colitis	3.3e-06	4.23e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL2—ulcerative colitis	3.3e-06	4.22e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	3.29e-06	4.21e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	3.29e-06	4.21e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	3.29e-06	4.21e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	3.25e-06	4.16e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ADCY5—ulcerative colitis	3.24e-06	4.15e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS1—ulcerative colitis	3.23e-06	4.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	3.22e-06	4.12e-05	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.21e-06	4.11e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.21e-06	4.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	3.19e-06	4.09e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ABCB1—ulcerative colitis	3.19e-06	4.09e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	3.16e-06	4.05e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.15e-06	4.04e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	3.15e-06	4.03e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	3.13e-06	4e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP9—ulcerative colitis	3.12e-06	3.99e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	3.09e-06	3.96e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	3.09e-06	3.96e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CALM3—ulcerative colitis	3.09e-06	3.96e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NFKB1—ulcerative colitis	3.09e-06	3.95e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	3.08e-06	3.94e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	3.07e-06	3.93e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	3.02e-06	3.87e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ABCB1—ulcerative colitis	3.01e-06	3.85e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3e-06	3.84e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ADCY5—ulcerative colitis	2.98e-06	3.81e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PPARG—ulcerative colitis	2.98e-06	3.81e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PPARG—ulcerative colitis	2.97e-06	3.8e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	2.96e-06	3.79e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	2.92e-06	3.74e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CALM3—ulcerative colitis	2.91e-06	3.73e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.89e-06	3.7e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	2.88e-06	3.68e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	2.86e-06	3.66e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	2.81e-06	3.6e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ADCY5—ulcerative colitis	2.81e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—ulcerative colitis	2.79e-06	3.58e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	2.78e-06	3.56e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—STAT3—ulcerative colitis	2.77e-06	3.55e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.76e-06	3.53e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	2.75e-06	3.52e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS1—ulcerative colitis	2.74e-06	3.51e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	2.71e-06	3.47e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.7e-06	3.45e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	2.69e-06	3.44e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—ulcerative colitis	2.68e-06	3.43e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—ulcerative colitis	2.67e-06	3.42e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	2.61e-06	3.34e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	2.58e-06	3.3e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—ulcerative colitis	2.57e-06	3.29e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	2.5e-06	3.2e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	2.47e-06	3.16e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CALM3—ulcerative colitis	2.47e-06	3.16e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PPARG—ulcerative colitis	2.42e-06	3.1e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	2.39e-06	3.06e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.36e-06	3.02e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—ulcerative colitis	2.34e-06	3e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.34e-06	2.99e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ABCB1—ulcerative colitis	2.26e-06	2.9e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	2.25e-06	2.88e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	2.25e-06	2.88e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.25e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ADCY5—ulcerative colitis	2.24e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	2.23e-06	2.85e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARG—ulcerative colitis	2.22e-06	2.84e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	2.2e-06	2.82e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	2.18e-06	2.79e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—ulcerative colitis	2.17e-06	2.78e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	2.16e-06	2.76e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	2.15e-06	2.76e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	2.14e-06	2.74e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	2.13e-06	2.73e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—ulcerative colitis	2.12e-06	2.72e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—ulcerative colitis	2.12e-06	2.71e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.11e-06	2.71e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.11e-06	2.71e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.09e-06	2.68e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARG—ulcerative colitis	2.09e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	2.08e-06	2.66e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	2.05e-06	2.63e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	2.05e-06	2.62e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	2.04e-06	2.61e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	2.03e-06	2.6e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	2.02e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	2.02e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	2.01e-06	2.57e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—ulcerative colitis	2e-06	2.56e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	1.98e-06	2.54e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	1.96e-06	2.51e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	1.95e-06	2.5e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	1.94e-06	2.49e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—ulcerative colitis	1.94e-06	2.49e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—ulcerative colitis	1.94e-06	2.48e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	1.93e-06	2.48e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ABCB1—ulcerative colitis	1.92e-06	2.46e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	1.92e-06	2.46e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	1.91e-06	2.44e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.9e-06	2.44e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—ulcerative colitis	1.9e-06	2.44e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	1.9e-06	2.43e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—ulcerative colitis	1.88e-06	2.41e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	1.87e-06	2.39e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	1.86e-06	2.38e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	1.84e-06	2.35e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	1.84e-06	2.35e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	1.82e-06	2.33e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	1.82e-06	2.33e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	1.82e-06	2.32e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	1.82e-06	2.32e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	1.81e-06	2.32e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	1.81e-06	2.31e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	1.8e-06	2.3e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ADCY5—ulcerative colitis	1.79e-06	2.29e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	1.79e-06	2.29e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	1.78e-06	2.28e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	1.76e-06	2.26e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—ulcerative colitis	1.75e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	1.72e-06	2.2e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	1.7e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	1.69e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	1.69e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	1.68e-06	2.15e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	1.67e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—ulcerative colitis	1.67e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	1.66e-06	2.13e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	1.65e-06	2.11e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—ulcerative colitis	1.65e-06	2.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	1.64e-06	2.1e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	1.64e-06	2.09e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	1.61e-06	2.07e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	1.59e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	1.58e-06	2.02e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—ulcerative colitis	1.58e-06	2.02e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.56e-06	2e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	1.54e-06	1.98e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	1.53e-06	1.96e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	1.53e-06	1.96e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	1.52e-06	1.94e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—ulcerative colitis	1.5e-06	1.92e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	1.5e-06	1.92e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	1.5e-06	1.92e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	1.5e-06	1.92e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	1.49e-06	1.9e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.48e-06	1.9e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	1.47e-06	1.89e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	1.47e-06	1.88e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—ulcerative colitis	1.42e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	1.42e-06	1.81e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—ulcerative colitis	1.4e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	1.4e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	1.39e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	1.38e-06	1.77e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.38e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	1.38e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	1.34e-06	1.71e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.33e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.32e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	1.27e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	1.26e-06	1.61e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	1.25e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	1.24e-06	1.59e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.24e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	1.24e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	1.23e-06	1.58e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.23e-06	1.57e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—ulcerative colitis	1.2e-06	1.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	1.17e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	1.15e-06	1.48e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	1.15e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	1.15e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	1.14e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	1.13e-06	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	1.07e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.05e-06	1.34e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	1.05e-06	1.34e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.03e-06	1.32e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	1.02e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	9.47e-07	1.21e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	9.33e-07	1.19e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—ulcerative colitis	9.26e-07	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	8.67e-07	1.11e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—ulcerative colitis	8.1e-07	1.04e-05	CbGpPWpGaD
